SUMMARY A previously healthy 53-year-old man had keratitis of the right eye for six months, unresponsive to topical medical therapy. Acanthamoeba was grown from tissue obtained by corneal biopsy and from aqueous from an anterior chamber tap. The patient was treated with propamidine isethionate 0-1% drops and dibromopropamidine isethionate 0)15% ointment, and after two and a half months the ocular inflammation was continuing to resolve. This case supports a role for the diamidines in the treatment of acanthamoebic keratitis.
Acanthamoebic keratitis is a serious sight threatening condition. It can be difficult to diagnose and very difficult to treat. Despite an increasing number of reports ophthalmologists must base their knowledge of the condition on anecdotal reports of those cases which provide insight into the clinical problem. This report is of a man who had a persistent hypopyon from which the organism was recovered, and who responded to topical administration of propamidine isethionate and dibromopropamidine isethionate.
Acanthamoeba species have now been reported many times as having caused protracted keratitis unresponsive to medical therapy.'1-Reports of successful medical treatment are few. Of these, one has been of treatment with a combination of propamidine isethionate drops 0-1%, dibromopropamidine isethionate 0*15% ointment, and neomycin drops' and another of treatment with topical miconazole 10 mg/ml, polymyxin-neomycingramicidin, and propamidine isethionate.'3 The case reported here supports a role for diamidines in the medical management of acanthamoebic keratitis.
Case report
A healthy 53-year-old man was referred with right keratitis, unresponsive to treatment with topical prednisolone acetate 1% and acyclovir during the preceding month. He remembered no episodes of ocular trauma but had had an attack of keratitis four years previously which healed within two weeks of beginning topical antiviral therapy. On examination, visual acuity in the right eye was hand movements at I m, in the left eye 6/5. In the right eye there was a large central corneal epithelial defect overlying an area of stromal inflammation which extended to the corneal mid-periphery, where the pacification wats denser (Fig. 1) . Iris details could not be seen. Corneal scrapings grew Staphylococcus epidermidis, and topical treatment was continued with vidarabine ointment, prednisolone sodium phosphate 03-%, and atropine Lao drops.
After five weeks the anterior segment inflammation had increased and a hypopyon was evident (Fig.  2) . On several occasions during the next two months cultures for bacteria, fungi, and amoebae were negative, and the hypopyon persisted, accompanied by severe ocular pain. At the end of this time the corneal opacity was dense, but the corneal epithelial defect had begun to heal and was completely epithelialised three months after the patient's initial presentation.
For the next two months the condition remained unchanged. At the end of this time aqueous from an anterior chamber tap showed unusual eosinophils but no causative organism. One week later, and six months after the onset of the keratitis, corneal biopsy was performed, with repeat anterior chamber tap. Acanthamoeba grew from both specimens after five days, though none was seen in the histopathological sections of the corneal biopsy. Morphologically, the organism was similar to but not identical with A canthatnoeba polyp haga.
Because of the extent of anterior segment inflammation and the presence of amoebae in the aqueous humour, medical treatment was preferred to surgical excision and corneal grafting. Treatment was started with propamidine isethionate () I°/O drops two hourly, dibromopropamidine isethionate 0( 15% ointment at night, prednisolone acetate 1Io drops every two hours, and atropine 1% 'o drops twice daily.
After three weeks there were signs of improvement, with less anterior segment inflammation, disappearance of the hypopyon, and clearing of the stromal infiltrate and oedema, allowing some view of the iris details. This improvement was maintained during the next month; but, with recurrence of a central epithelial defect (Fig. 3) , treatment was reduced to propamidine isethionate 0( 100 drops and prednisolone acetate I 'So drops, each four times a day, and atropine I % drops twice daily. The eye was padded. The epithelial defect healed within one week, but further reduction of propamidine isethionate 0-1(Yo to twice daily resulted in a rapid increase in anterior segment inflammation.
Subsequently the patient received propamidine isethionate 0-1%0 drops four times a day and dibro- 12 The diamidines are also toxic to a number of different protozoa, but their mechanism of action has not yet been established." Wright and colleagues' showed that propamidine and dibromopropamidine isethionate have acted in vitro against both cysts and trophozoites of acanthamoeba and that, clinically, there were no adverse reactions to these drugs during two months' treatment.
The case reported here further supports the place of propamidine and dibromopropamidine isethionate in the treatment of acanthamoebic keratitis and also emphasises the useful role of corneal biopsy in the diagnosis of this condition. 
